Financhill
Sell
37

JSPR Quote, Financials, Valuation and Earnings

Last price:
$1.65
Seasonality move :
45.02%
Day range:
$1.51 - $1.58
52-week range:
$1.39 - $7.19
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.70x
Volume:
258.2K
Avg. volume:
902.7K
1-year change:
-73.16%
Market cap:
$42.8M
Revenue:
--
EPS (TTM):
-$5.90

Earnings Data

Next earnings date for JSPR
Feb 26
2026
Most recent earnings per share
-$1.13
Beat by $0.17
(Nov 10/2025)
Consensus Estimate
-$1.29
(Nov 10/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

JSPR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.68 --
02/26/2026 Q4 -- -- -- -$0.87 --
11/10/2025 Q3 -- -- -$1.13 -$1.29 $0.17
08/13/2025 Q2 -- -- -$1.74 -$1.33 -$0.42
05/14/2025 Q1 -- -- -$1.41 -$1.48 $0.06
02/27/2025 Q4 -- -- -$1.62 -$1.23 -$0.39
11/07/2024 Q3 -- -- -$1.24 -$1.08 -$0.16
08/13/2024 Q2 -- -- -$0.97 -$1.12 $0.15
05/14/2024 Q1 -- -- -$1.03 -$1.18 $0.15
03/04/2024 Q4 -- -- -$1.50 -$1.57 $0.07
11/09/2023 Q3 -- -- -$1.60 -$1.50 -$0.10
08/11/2023 Q2 -- -- -$1.47 -$1.47 -$0.00
05/12/2023 Q1 -- -- -$1.62 -$1.50 -$0.12
03/08/2023 Q4 -- -- -$3.60 -$4.00 $0.40
11/11/2022 Q3 -- -- -$3.20 -$3.70 $0.50
08/12/2022 Q2 -- -- -$2.90 -- --
05/12/2022 Q1 -- -- -$0.60 -- --
03/18/2022 Q4 -- -- -$2.39 -- --
11/12/2021 Q3 -- -- -$6.90 -- --
06/30/2021 Q2 -- -- -$2.22 -- --
03/31/2021 Q1 -- -- -$2.58 -- --
12/31/2020 Q4 -- -- -$2.64 -- --
09/30/2020 Q3 -- -- -$2.86 -- --

Jasper Therapeutics, Inc. Earnings Questions

  • How Much did Jasper Therapeutics, Inc. Generate in Revenue Last Quarter?

    Jasper Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Jasper Therapeutics, Inc. Beat Earnings Last Quarter?

    Jasper Therapeutics, Inc. announced earnings per share of -$1.13 which represents a beat of analyst forecast a -$1.29 per share.

  • Is Jasper Therapeutics, Inc. Profitable?

    Jasper Therapeutics, Inc. reported -$229K that represents -$0.01 per share over the last quarter.

  • What is the Analyst Consensus for Jasper Therapeutics, Inc. EPS Next Year?

    Jasper Therapeutics, Inc.'s earnings are forecast to decrease from -$4.89 per share to -$4.90 per share next year representing a decrease of -32.57%.

  • When is Jasper Therapeutics, Inc.'s Earnings Date?

    Jasper Therapeutics, Inc.'s next earnings date is February 26, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Is Palantir Stock Going to Crash?
Is Palantir Stock Going to Crash?

AI and data analytics major Palantir (NASDAQ:PLTR) has become something…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
52
CVLT alert for Jan 27

Commvault Systems, Inc. [CVLT] is down 31.05% over the past day.

Sell
47
AGYS alert for Jan 27

Agilysys, Inc. [AGYS] is down 20.21% over the past day.

Buy
71
GLSI alert for Jan 27

Greenwich LifeSciences, Inc. [GLSI] is up 5.98% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock